A C Alman1, D R Jacobs2, C E Lewis3, J K Snell-Bergeon4, M R Carnethon5, J G Terry6, D C Goff7, J Ding8, J J Carr6. 1. Department of Epidemiology and Biostatistics, College of Public Health, University of South Florida, 13201 Bruce B Downs Blvd, MDC 56, Tampa, FL 33612-3805, USA. Electronic address: aalman@health.usf.edu. 2. Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA. 3. Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. 4. Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. 5. Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. 6. Department of Radiology, Vanderbilt University School of Medicine, Nashville, TN, USA; Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN, USA; Department of Cardiovascular Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA. 7. Colorado School of Public Health, Aurora, CO, USA. 8. Sticht Center on Aging, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Abstract
BACKGROUND AND AIMS: Pericardial adipose tissue (PAT) is located on both sides of the pericardium. We tested whether PAT was associated with prevalent diabetes at the year 25 exam of the Coronary Artery Risk Development in Young Adults (CARDIA) study. METHODS AND RESULTS: The CARDIA Year 25 exam (2010-2011) included complete data for all covariates on 3107 participants. Prevalent diabetes (n = 436) was defined as high fasting (≥126 mg/dl) or 2-h postload glucose (≥200 mg/dl) or HbA1c (≥6.5%) or use of diabetes medications. Volume of PAT was measured from computed tomographic scans. Logistic regression was performed to examine the relationship between quartiles of PAT and diabetes. In regression models adjusted for field center, sex, race, age, systolic blood pressure, total cholesterol, log triglycerides, and treatment with blood pressure and cholesterol lowering medication, PAT volume in the 4th quartile was significantly associated with diabetes status after adjustment for BMI (OR 2.57, 95% CI 1.66, 3.98) or visceral adipose tissue (OR 2.08, 95% CI 1.32, 3.29). PAT volume in the 2nd and 3rd quartiles was not significantly associated with diabetes status relative to the first quartile. CONCLUSIONS: Metabolically active pericardial adipose tissue is associated with prevalent diabetes only at higher volumes independent of overall obesity.
BACKGROUND AND AIMS: Pericardial adipose tissue (PAT) is located on both sides of the pericardium. We tested whether PAT was associated with prevalent diabetes at the year 25 exam of the Coronary Artery Risk Development in Young Adults (CARDIA) study. METHODS AND RESULTS: The CARDIA Year 25 exam (2010-2011) included complete data for all covariates on 3107 participants. Prevalent diabetes (n = 436) was defined as high fasting (≥126 mg/dl) or 2-h postload glucose (≥200 mg/dl) or HbA1c (≥6.5%) or use of diabetes medications. Volume of PAT was measured from computed tomographic scans. Logistic regression was performed to examine the relationship between quartiles of PAT and diabetes. In regression models adjusted for field center, sex, race, age, systolic blood pressure, total cholesterol, log triglycerides, and treatment with blood pressure and cholesterol lowering medication, PAT volume in the 4th quartile was significantly associated with diabetes status after adjustment for BMI (OR 2.57, 95% CI 1.66, 3.98) or visceral adipose tissue (OR 2.08, 95% CI 1.32, 3.29). PAT volume in the 2nd and 3rd quartiles was not significantly associated with diabetes status relative to the first quartile. CONCLUSIONS: Metabolically active pericardial adipose tissue is associated with prevalent diabetes only at higher volumes independent of overall obesity.
Authors: Guy L Wheeler; Rong Shi; Stephanie R Beck; Carl D Langefeld; Leon Lenchik; Lynne E Wagenknecht; Barry I Freedman; Stephen S Rich; Donald W Bowden; Michael Y Chen; J Jeffrey Carr Journal: Invest Radiol Date: 2005-02 Impact factor: 6.016
Authors: G D Friedman; G R Cutter; R P Donahue; G H Hughes; S B Hulley; D R Jacobs; K Liu; P J Savage Journal: J Clin Epidemiol Date: 1988 Impact factor: 6.437
Authors: Tomasz Mazurek; LiFeng Zhang; Andrew Zalewski; John D Mannion; James T Diehl; Hwyda Arafat; Lea Sarov-Blat; Shawn O'Brien; Elizabeth A Keiper; Anthony G Johnson; Jack Martin; Barry J Goldstein; Yi Shi Journal: Circulation Date: 2003-10-27 Impact factor: 29.690
Authors: S R El Khoudary; C Shin; K Masaki; K Miura; M Budoff; D Edmundowicz; S Kadowaki; E Barinas-Mitchell; A El-Saed; A Fujiyoshi; R W Evans; T Hisamatsu; T Ohkubo; B J Willcox; L H Kuller; H Ueshima; A Sekikawa Journal: Int J Obes (Lond) Date: 2014-08-11 Impact factor: 5.095
Authors: Minsuk Oh; David R Jacobs; Kelley Pettee Gabriel; Wei Bao; Gary L Pierce; Lucas J Carr; Jingzhong Ding; Kara M Whitaker Journal: Med Sci Sports Exerc Date: 2022-01-25
Authors: Samuel S Bailin; Curtis L Gabriel; Run Fan; Fei Ye; Sangeeta Nair; James G Terry; John J Carr; Heidi Silver; Celestine N Wanjalla; Mona Mashayekhi; Morgan Lima; Beverly Woodward; LaToya Hannah; Hubaida Fuseini; Jane F Ferguson; Jonathan A Kropski; John R Koethe Journal: J Acquir Immune Defic Syndr Date: 2022-06-01 Impact factor: 3.771
Authors: Minsuk Oh; Kelley Pettee Gabriel; David R Jacobs; Wei Bao; Gary L Pierce; Lucas J Carr; James G Terry; Jingzhong Ding; John Jeffrey Carr; Kara M Whitaker Journal: Am J Cardiol Date: 2022-03-20 Impact factor: 3.133
Authors: Morgana Mongraw-Chaffin; Unjali P Gujral; Alka M Kanaya; Namratha R Kandula; John Jeffrey Carr; Cheryl A M Anderson Journal: Am J Cardiol Date: 2017-10-31 Impact factor: 2.778
Authors: So-Yun Yi; Lyn M Steffen; James G Terry; David R Jacobs; Daniel Duprez; Brian T Steffen; Xia Zhou; James M Shikany; Lisa Harnack; John J Carr Journal: Eur J Prev Cardiol Date: 2020-06-28 Impact factor: 7.804
Authors: Duke Appiah; Cora E Lewis; David R Jacobs; James M Shikany; Charles P Quesenberry; Myron Gross; Jeff Carr; Stephen Sidney; Erica P Gunderson Journal: J Clin Endocrinol Metab Date: 2021-05-13 Impact factor: 5.958
Authors: Evan L Brittain; Chike Nwabuo; Meng Xu; Deepak K Gupta; Anna R Hemnes; Henrique T Moreira; Henrique Doria De Vasconcellos; James G Terry; Jeffrey J Carr; Joao A C Lima Journal: J Am Heart Assoc Date: 2017-03-30 Impact factor: 5.501
Authors: Curtis L Gabriel; Fei Ye; Run Fan; Sangeeta Nair; James G Terry; John Jeffrey Carr; Heidi Silver; Paxton Baker; LaToya Hannah; Celestine Wanjalla; Mona Mashayekhi; Sam Bailin; Morgan Lima; Beverly Woodward; Manhal Izzy; Jane F Ferguson; John R Koethe Journal: Hepatol Commun Date: 2021-02-27
Authors: James G Terry; Christina M Shay; Pamela J Schreiner; David R Jacobs; Otto A Sanchez; Jared P Reis; David C Goff; Samuel S Gidding; Lyn M Steffen; John Jeffrey Carr Journal: Arterioscler Thromb Vasc Biol Date: 2017-10-12 Impact factor: 10.514